MET and neoplasm: Preclinical data indicate that a combination of VEGF pathway and MET inhibition can be effective in targeting tumour angiogenesis and suppressing tumour growth and metastasis (Shojaei et al, 2010; Aftab and McDonald, 2011; Sennino et al, 2012; Shojaei et al, 2012).